U.S. flag

An official website of the United States government

NM_001287.6(CLCN7):c.381G>A (p.Trp127Ter) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 26, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002858255.3

Allele description [Variation Report for NM_001287.6(CLCN7):c.381G>A (p.Trp127Ter)]

NM_001287.6(CLCN7):c.381G>A (p.Trp127Ter)

Gene:
CLCN7:chloride voltage-gated channel 7 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16p13.3
Genomic location:
Preferred name:
NM_001287.6(CLCN7):c.381G>A (p.Trp127Ter)
HGVS:
  • NC_000016.10:g.1460919C>T
  • NG_007567.1:g.19166G>A
  • NM_001114331.3:c.309G>A
  • NM_001287.6:c.381G>AMANE SELECT
  • NP_001107803.1:p.Trp103Ter
  • NP_001278.1:p.Trp127Ter
  • NC_000016.9:g.1510920C>T
Protein change:
W103*
Molecular consequence:
  • NM_001114331.3:c.309G>A - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001287.6:c.381G>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003234801Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 26, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis.

Frattini A, Pangrazio A, Susani L, Sobacchi C, Mirolo M, Abinun M, Andolina M, Flanagan A, Horwitz EM, Mihci E, Notarangelo LD, Ramenghi U, Teti A, Van Hove J, Vujic D, Young T, Albertini A, Orchard PJ, Vezzoni P, Villa A.

J Bone Miner Res. 2003 Oct;18(10):1740-7.

PubMed [citation]
PMID:
14584882

Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: report of 20 novel mutations.

Pangrazio A, Pusch M, Caldana E, Frattini A, Lanino E, Tamhankar PM, Phadke S, Lopez AG, Orchard P, Mihci E, Abinun M, Wright M, Vettenranta K, Bariae I, Melis D, Tezcan I, Baumann C, Locatelli F, Zecca M, Horwitz E, Mansour LS, Van Roij M, et al.

Hum Mutat. 2010 Jan;31(1):E1071-80. doi: 10.1002/humu.21167.

PubMed [citation]
PMID:
19953639
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003234801.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with CLCN7-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp127*) in the CLCN7 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CLCN7 are known to be pathogenic (PMID: 14584882, 19953639).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024